Direct evidence of cell-surface heparan sulfate proteoglycans (HSPG) as diagnostic tools for promoting or preventing tumor progression has been lacking. Others and we have demonstrated that heparanase (Hpa-1) is a key determinant in invasive and metastatic events, and cleaves the HS chains of HSPG at specific intrachain sites. Although Hpa-1 represents the first example of purification and cloning of a mammalian HS degradative enzyme, a gene (hpa-2) related to hpa-1 has been recently cloned, and the gene product named heparanase-2 or Hpa-2. Being in the unique position of having access to newly developed Hpa-2 and Hpa-1 molecular probes, we have been studying mechanisms of heparanases in brain-metastatic melanoma (BMM) models as purified enzymes, antigens, and genes. We have found that Hpa-2 treatment of BMM cells results in opposite effects on brain colonization when compared to a corresponding Hpa-1 exposure. Our central hypothesis is that heparanases/HSPG processing is critical in invasion and metastasis, and targets for anti-cancer therapeutics. Hypotheses for this application are: 1) tumor cell surface HS contain bioactive sequences that impinge on melanoma growth and brain metastasis formation, and 2) HS chains from HSPG act as cryptic inhibitors or promoters of BMM upon their selective degradation by heparanases. The work proposed addresses research priorities raised by the N.C.I. Brain Tumor PRG report for an improved understanding of mechanisms underlying the establishment and spread of brain metastasis. We plan to demonstrate our hypotheses by pursuing the following specific aims: 1. To characterize Hpa-2 expression modalities in brain-metastatic melanoma (BMM) and relate them to Hpa-1 and to patient outcome. 2. To determine mechanisms by which a differential HS degradation specificity by heparanases results in inhibition or promotion of brain metastasis. These studies will assert 1) the relevance of heparanases (in particular Hpa-2) in cancer biology, and 2) the importance of HS chains as promoters or inhibitors of melanoma growth and metastasis, specifically to the brain. They will provide a framework for the development of polysaccharide-based anti-cancer molecules as important prognostic tools and diagnostic screens for metastatic detection, diagnosis and treatment.

Agency
National Institute of Health (NIH)
Institute
National Cancer Institute (NCI)
Type
Exploratory/Developmental Grants (R21)
Project #
5R21CA103955-02
Application #
6865640
Study Section
Cancer Molecular Pathobiology Study Section (CAMP)
Program Officer
Thurin, Magdalena
Project Start
2004-03-13
Project End
2006-08-31
Budget Start
2005-03-01
Budget End
2006-08-31
Support Year
2
Fiscal Year
2005
Total Cost
$132,300
Indirect Cost
Name
Louisiana State University A&M Col Baton Rouge
Department
Veterinary Sciences
Type
Schools of Veterinary Medicine
DUNS #
075050765
City
Baton Rouge
State
LA
Country
United States
Zip Code
70803
Roy, Madhuchhanda; Marchetti, Dario (2009) Cell surface heparan sulfate released by heparanase promotes melanoma cell migration and angiogenesis. J Cell Biochem 106:200-9
D'Souza, Sonia; Yang, Weidong; Marchetti, Dario et al. (2008) HIP/RPL29 antagonizes VEGF and FGF2 stimulated angiogenesis by interfering with HS-dependent responses. J Cell Biochem 105:1183-93
Marchetti, D; Mrak, R E; Paulsen, D D et al. (2007) Neurotrophin receptors and heparanase: a functional axis in human medulloblastoma invasion. J Exp Clin Cancer Res 26:5-23
Reiland, Jane; Kempf, Doty; Roy, Madhuchhanda et al. (2006) FGF2 binding, signaling, and angiogenesis are modulated by heparanase in metastatic melanoma cells. Neoplasia 8:596-606
Moretti, Massimo; Sinnappah-Kang, Neeta Devi; Toller, Matteo et al. (2006) HPSE-1 expression and functionality in differentiating neural cells. J Neurosci Res 83:694-701
Sinnappah-Kang, Neeta D; Mrak, Robert E; Paulsen, Daniel B et al. (2006) Heparanase expression and TrkC/p75NTR ratios in human medulloblastoma. Clin Exp Metastasis 23:55-63
Denkins, Yvonne; Kempf, Doty; Ferniz, Melissa et al. (2005) Role of omega-3 polyunsaturated fatty acids on cyclooxygenase-2 metabolism in brain-metastatic melanoma. J Lipid Res 46:1278-84
Sinnappah-Kang, Neeta D; Kaiser, Adam J; Blust, Bryan E et al. (2005) Heparanase, TrkC and p75NTR: their functional involvement in human medulloblastoma cell invasion. Int J Oncol 27:617-26